Overexpression of flavin-containing monooxygenase 5 predicts poor prognosis in patients with colorectal cancer

  • Authors:
    • Tong Zhang
    • Ping Yang
    • Jianchang Wei
    • Wanglin Li
    • Junbin Zhong
    • Huacui Chen
    • Jie Cao
  • View Affiliations

  • Published online on: January 4, 2018     https://doi.org/10.3892/ol.2018.7724
  • Pages: 3923-3927
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The present study investigated the expression and clinical significance of flavin‑containing monooxygenase 5 (FMO5) in colorectal cancer (CRC). The expression of FMO5 was detected by immunohistochemistry in 208 colon cancer tissues and 8 normal colon tissues. Then, the correlations of FMO5 expression with several clinicopathological features were evaluated. FMO5 mRNA expression from The Cancer Genome Atlas dataset was assessed for further validation. In addition, the association of the expression of FMO5 with prognosis was further evaluated by Kaplan‑Meier survival curves and Cox proportional hazards model. The FMO5 protein level in colon cancer tissues was significantly higher than that in normal colon tissues (P<0.001). Overexpression of FMO5 was associated with an advanced clinical stage of cancer (P=0.018) and lymph node metastasis (P=0.03). The TCGA dataset also demonstrated that FMO5 was upregulated in CRC with advanced clinical stage (P=0.047), lymph node metastasis (P=0.045) and distant metastasis (P=0.030). The Kaplan‑Meier survival curves showed that higher FMO5 mRNA indicated a shorter overall survival in patients with CRC compared with a low expression of FMO5 (P=0.029). Cox proportional hazards regression revealed that a high FMO5 mRNA level served as an independent prognostic factor for patients with CRC (hazard ratio, 2.865; 95% confidence interval, 1.116‑7.355; P=0.029). A high expression of FMO5 may serve roles in colorectal carcinogenesis and distant metastasis. FMO5 may be an independent predictive factor for the prognosis of CRC.
View Figures
View References

Related Articles

Journal Cover

March-2018
Volume 15 Issue 3

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhang T, Yang P, Wei J, Li W, Zhong J, Chen H and Cao J: Overexpression of flavin-containing monooxygenase 5 predicts poor prognosis in patients with colorectal cancer. Oncol Lett 15: 3923-3927, 2018
APA
Zhang, T., Yang, P., Wei, J., Li, W., Zhong, J., Chen, H., & Cao, J. (2018). Overexpression of flavin-containing monooxygenase 5 predicts poor prognosis in patients with colorectal cancer. Oncology Letters, 15, 3923-3927. https://doi.org/10.3892/ol.2018.7724
MLA
Zhang, T., Yang, P., Wei, J., Li, W., Zhong, J., Chen, H., Cao, J."Overexpression of flavin-containing monooxygenase 5 predicts poor prognosis in patients with colorectal cancer". Oncology Letters 15.3 (2018): 3923-3927.
Chicago
Zhang, T., Yang, P., Wei, J., Li, W., Zhong, J., Chen, H., Cao, J."Overexpression of flavin-containing monooxygenase 5 predicts poor prognosis in patients with colorectal cancer". Oncology Letters 15, no. 3 (2018): 3923-3927. https://doi.org/10.3892/ol.2018.7724